RecruitingNCT07409584

Mental Health and Suicidality in Glioblastoma Patients in Germany

Mental Health and Suicidality in Glioblastoma Patients in Germany - a Multicenter Observational Study (SHINE-GLIO Study)

Sponsor

University Hospital, Essen

Enrollment

176 participants

Start Date

Mar 19, 2026

Study Type

OBSERVATIONAL

Conditions

Glioblastoma (GBM)

Summary

The aim of the study is to use standardized questionnaires to systematically record influencing factors or predictors for suicidal behavior in glioblastoma patients, particularly with regard to existing depression and anxiety symptoms.

Eligibility

Min Age: 18 Years

Inclusion Criteria2

Diagnosis of glioblastoma, IDH wild-type (CNS WHO classification of 2021)
Age ≥ 18 years

Exclusion Criteria3

Participants with clinically significant aphasia or language barrier as assessed by the investigator
History of other malignant tumors
Known tumor predisposition syndrome (e.g., Li-Fraumeni syndrome, Cowden syndrome, etc.)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTMedical history, physical examination, completing questionnaires, data collection

Medical history Physical examination Completion of validated questionnaires: * Suicide Scale (SSEV) * Patient Health Questionnaire-8 (PHQ-8) * Generalized Anxiety Disorder-7 (GAD-7) * EORTC-QLQ-30 * EORTC-QLQ-BN-20 * Short questionnaire on social support for chronic illnesses (SUCE-4) Data collection from medical records